Refine
Has Fulltext
- yes (16)
Is part of the Bibliography
- yes (16)
Document Type
- Journal article (15)
- Doctoral Thesis (1)
Keywords
- hypofractionation (3)
- prostate cancer (3)
- Halcyon (2)
- IGRT (2)
- cone beam CT (2)
- image-guided radiation therapy (2)
- long-term outcome (2)
- radiotherapy (2)
- toxicity (2)
- 4D-MRI (1)
- CIED malfunction; pacemaker (PM) (1)
- DC-Gating (1)
- Kernspintomografie (1)
- Lung Imaging (1)
- Lunge (1)
- Lungenbildbgebung (1)
- Magnetresonanztomographie (1)
- Non-rigid image registration (1)
- Radiotherapy treatment planning (1)
- Respiratory induced tumor motion (1)
- Retrospective Motion Compensation (1)
- Retrospektive Bewegungskorrektur (1)
- Synergy (1)
- VMAT (1)
- acute toxicity (1)
- adaptation (1)
- auto-planning (1)
- battery depletion (1)
- biochemical relapse free survival (1)
- cardiac implantable electronic devices (CIED) (1)
- cardiac resynchronization therapy (CRT) (1)
- dose escalation (1)
- dose evaluation (1)
- dose to OARs (1)
- double arc (1)
- dual-energy CT (1)
- dual-source CT (1)
- external beam radiotherapy (EBRT) (1)
- free breathing (1)
- free‐breathing (1)
- freie Atmung (1)
- full arc (1)
- high-dose-rate (HDR) brachytherapy (1)
- high-dose-rate brachytherapy boost (1)
- implantable cardioverter defibrillator (ICD) (1)
- intensity-modulated radiation therapy (1)
- local control (1)
- lung (1)
- lung cancer (1)
- multimodal therapy (1)
- multiple brain metastases (1)
- obesity (1)
- partial arc (1)
- plan comparison (1)
- propensity score matching (1)
- radiation dose (1)
- radiotherapy (RT) (1)
- re-irradiation (1)
- re-planning (1)
- rectal cancer (1)
- self‐gated (1)
- setup verification (1)
- simultaneous integrated boost (1)
- single arc (1)
- spectral CT (1)
- thoracic cancer (1)
- transperineal ultrasound (1)
- treatment plan (1)
- virtual non-contrast (1)
- wave‐CAIPI (1)
- whole breast irradiation (1)
Institute
- Klinik und Poliklinik für Strahlentherapie (13)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (3)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
- Institut für Medizinische Strahlenkunde und Zellforschung (1)
- Klinik und Poliklinik für Nuklearmedizin (1)
- Medizinische Klinik und Poliklinik I (1)
- Physikalisches Institut (1)
Purpose
Evaluation of clinical outcome of two-weekly high-dose-rate brachytherapy boost after external beam radiotherapy (EBRT) for localized prostate cancer.
Methods
338 patients with localized prostate cancer receiving definitive EBRT followed by a two-weekly high-dose-rate brachytherapy boost (HDR-BT boost) in the period of 2002 to 2019 were analyzed. EBRT, delivered in 46 Gy (DMean) in conventional fractionation, was followed by two fractions HDR-BT boost with 9 Gy (D90%) two and four weeks after EBRT. Androgen deprivation therapy (ADT) was added in 176 (52.1%) patients. Genitourinary (GU)/gastrointestinal (GI) toxicity was evaluated utilizing the Common Toxicity Criteria for Adverse Events (version 5.0) and biochemical failure was defined according to the Phoenix definition.
Results
Median follow-up was 101.8 months. 15 (4.4%)/115 (34.0%)/208 (61.5%) patients had low-/intermediate-/high-risk cancer according to the D`Amico risk classification. Estimated 5-year and 10-year biochemical relapse-free survival (bRFS) was 84.7% and 75.9% for all patients. The estimated 5-year bRFS was 93.3%, 93.4% and 79.5% for low-, intermediate- and high-risk disease, respectively. The estimated 10-year freedom from distant metastasis (FFM) and overall survival (OS) rates were 86.5% and 70.0%. Cumulative 5-year late GU toxicity and late GI toxicity grade ≥ 2 was observed in 19.3% and 5.0% of the patients, respectively. Cumulative 5-year late grade 3 GU/GI toxicity occurred in 3.6%/0.3%.
Conclusions
Two-weekly HDR-BT boost after EBRT for localized prostate cancer showed an excellent toxicity profile with low GU/GI toxicity rates and effective long-term biochemical control.